gunnabe,
It sure looks that way. However, since it only takes $4 Million to gain control and the company is touting a $35 Million dollar revenue source, something doesn't add up.
Consider the possibility that the published conversion timetable was set up to mirror the laJolla funding and therefore mask it's true intention.
I find it interesting that Dutchess is still interested. It made some sense that they were willing to fund the takeover of Biofrontera, it makes less sense that they are willing to throw $35 miliion into the mix in the hope that DNAP will make something of it after the Biofrotera deal failed. Remember there is no way for them to profit from just the 'discount'.
frog